MedTrace Logo

Skin Cancer in Swiss Transplant Cohort Study

NCT02361229 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2019-07-29

No results posted yet for this study

Summary

It's known that organ transplant recipients with long-term drug-induced immunosuppression have a increase of the life-time incidence of squamous cell carcinoma. This study will analyze the incidence and type of skin cancer in the Swiss Transplant Cohort Study and the association with exposure to immunosuppressive and antiinfective drugs and other parameters like age or gender of organ transplant recipients.

Conditions

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Günther Hofbauer, Prof MD · University Hospital Zurich, Dermatology

Eligibility

Min Age
1 Hour
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2017-12-31
Completion
2019-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02361229 on ClinicalTrials.gov